These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 23727296

  • 41. Systemic consequences of COPD.
    Tkác J, Man SF, Sin DD.
    Ther Adv Respir Dis; 2007 Oct; 1(1):47-59. PubMed ID: 19124347
    [Abstract] [Full Text] [Related]

  • 42. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [Abstract] [Full Text] [Related]

  • 43. Chronic obstructive pulmonary disease is missed in asthmatics in specialty care in Trinidad, West Indies.
    Pinto Pereira LM, Bartholomew LA, Brooks H, Lowe D, Rocke K, Rolle S, Smith J, Thekwini O, Seemungal TA, Bekele I.
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1026-32. PubMed ID: 17705983
    [Abstract] [Full Text] [Related]

  • 44. [Spirometry and other pulmonary function tests for the screening and evaluation of patients with chronic obstructive pulmonary disease (COPD)].
    Yoshimi K, Seyama K.
    Nihon Rinsho; 2007 Apr; 65(4):664-9. PubMed ID: 17419385
    [Abstract] [Full Text] [Related]

  • 45. Diet and vitamin D as risk factors for lung impairment and COPD.
    Hanson C, Rutten EP, Wouters EF, Rennard S.
    Transl Res; 2013 Oct; 162(4):219-36. PubMed ID: 23685188
    [Abstract] [Full Text] [Related]

  • 46. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG.
    Am J Respir Crit Care Med; 2012 Nov 15; 186(10):982-8. PubMed ID: 22983959
    [Abstract] [Full Text] [Related]

  • 47. Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease.
    Rodríguez-Roisin R, Soriano JB.
    Proc Am Thorac Soc; 2008 Dec 01; 5(8):842-7. PubMed ID: 19017739
    [Abstract] [Full Text] [Related]

  • 48. The effect of airflow limitation on the cause of death in patients with COPD.
    Alfageme I, Reyes N, Merino M, Reina A, Gallego J, Lima J, Palacios Z.
    Chron Respir Dis; 2010 Aug 01; 7(3):135-45. PubMed ID: 20688891
    [Abstract] [Full Text] [Related]

  • 49. [Chronic obstructive pulmonary disease and cardiovascular diseases].
    Passowicz-Muszyńska E, Gostkowska-Malec A, Jankowska R, Piesiak P.
    Pneumonol Alergol Pol; 2010 Aug 01; 78(1):28-32. PubMed ID: 20162516
    [Abstract] [Full Text] [Related]

  • 50. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA, Abba AA, Al-Hajjaj MS, Alhamad EH, Raddaoui E, Shaikh SA.
    Respiration; 2011 Aug 01; 82(1):19-27. PubMed ID: 21282939
    [Abstract] [Full Text] [Related]

  • 51. Diagnostic management of chronic obstructive pulmonary disease.
    Broekhuizen BD, Sachs AP, Hoes AW, Verheij TJ, Moons KG.
    Neth J Med; 2012 Jan 01; 70(1):6-11. PubMed ID: 22271808
    [Abstract] [Full Text] [Related]

  • 52. COPD in Chinese nonsmokers.
    Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Wang X, Wang D, Liu S, Lu J, Zheng J, Zhong N, Ran P.
    Eur Respir J; 2009 Mar 01; 33(3):509-18. PubMed ID: 19251797
    [Abstract] [Full Text] [Related]

  • 53. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass.
    Ceylan E, Kocyigit A, Gencer M, Aksoy N, Selek S.
    Respir Med; 2006 Jul 01; 100(7):1270-6. PubMed ID: 16307872
    [Abstract] [Full Text] [Related]

  • 54. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J, Woźniak K, Banaszek M, Wiechno W, Domagała-Kulawik J.
    Pol Merkur Lekarski; 2009 Aug 01; 27(158):92-6. PubMed ID: 19856871
    [Abstract] [Full Text] [Related]

  • 55. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
    Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A.
    Respir Med; 2007 Aug 01; 101(8):1670-6. PubMed ID: 17449234
    [Abstract] [Full Text] [Related]

  • 56. [Chronic obstructive pulmonary disease and cardiovascular diseases--'cardiopulmonary continuum'].
    Batura-Gabryel H, Grabicki M.
    Pneumonol Alergol Pol; 2014 Aug 01; 82(6):590-6. PubMed ID: 25339571
    [Abstract] [Full Text] [Related]

  • 57. COPD and stroke: are systemic inflammation and oxidative stress the missing links?
    Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R.
    Clin Sci (Lond); 2016 Jul 01; 130(13):1039-50. PubMed ID: 27215677
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Chronic obstructive pulmonary disease as a risk factor for coronary heart disease].
    Jurczak I, Jurczak K.
    Pol Merkur Lekarski; 2015 Jan 01; 38(223):39-41. PubMed ID: 25763587
    [Abstract] [Full Text] [Related]

  • 60. Cardiovascular comorbidity in COPD: systematic literature review.
    Müllerova H, Agusti A, Erqou S, Mapel DW.
    Chest; 2013 Oct 01; 144(4):1163-1178. PubMed ID: 23722528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.